5/31/24 16:05 | 5/29/24 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P.m | 11 | 2.36 | 0 | 5 | 1 | 339 | D | | | | | | | | | | | | | | |
5/31/24 16:05 | 5/29/24 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DOT | P | P | 11 | 2.20 | 0 | 5 | 0 | 1,522 | I | | | | | | | | | | | | | | |
4/10/24 16:10 | 4/8/24 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DOT | P | P | 25 | 2.99 | 0 | 9 | 1 | 1,517 | I | | | | | | | | | | | | | | |
4/8/24 16:10 | 4/4/24 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DOT | P | P | 55 | 2.87 | 0 | 19 | 211 | 28 | I | | | | | | | | | | | | | | |
4/8/24 16:10 | 4/4/24 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P.m | 49 | 2.82 | 0 | 17 | 5 | 335 | I | | | | | | | | | | | | | | |
12/28/23 08:00 | 12/26/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Devall Christopher Franklin | NY | O | COO | P | 18 | 2.55 | 0 | 7 | 30 | 30 | D | | | | | | | | | | | | | | |
12/28/23 08:00 | 12/26/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DOT | P | P | 13 | 2.60 | 0 | 5 | 0 | 1,490 | I | | | | | | | | | | | | | | |
12/22/23 06:00 | 12/20/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 140 | 2.00 | 0 | 70 | 28 | 317 | I | | | | | | | | | | | | | | |
12/14/23 16:05 | 12/12/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 8 | 2.00 | 0 | 4 | 2 | 247 | I | | | | | | | | | | | | | | |
12/14/23 16:05 | 12/12/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DT | | P | 8 | 2.03 | 0 | 4 | 0 | 855 | I | | | | | | | | | | | | | | |
11/30/23 16:05 | 11/30/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Devall Christopher Franklin | NY | O | COO | P | 2 | 2.28 | 0 | 1 | 5 | 23 | D | | | | | | | | | | | | | | |
11/28/23 16:10 | 11/28/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Devall Christopher Franklin | NY | O | COO | P | 2 | 2.26 | 0 | 1 | 5 | 22 | D | | | | | | | | | | | | | | |
11/28/23 16:05 | 11/27/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | DT | | P | 2 | 2.20 | 0 | 1 | 0 | 851 | I | | | | | | | | | | | | | | |
11/27/23 16:05 | 11/22/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P.m | 6 | 2.13 | 0 | 3 | 1 | 243 | I | | | | | | | | | | | | | | |
11/21/23 16:05 | 11/20/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | D | | P | 4 | 2.05 | 0 | 2 | 0 | 850 | I | | | | | | | | | | | | | | |
11/20/23 06:01 | 11/16/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 5 | 1.97 | 0 | 3 | 1 | 241 | I | | | | | | | | | | | | | | |
11/15/23 17:23 | 11/14/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 5 | 1.93 | 0 | 3 | 1 | 238 | I | | | | | | | | | | | | | | |
9/22/23 08:30 | 9/20/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | D | | P | 39 | 2.62 | 0 | 15 | 2 | 848 | I | | | | | | | | | | | | | | |
9/22/23 08:30 | 9/20/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 39 | 2.59 | 0 | 15 | 7 | 236 | I | | | | | | | | | | | | | | |
9/20/23 16:05 | 9/19/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | D | | P | 5 | 2.55 | 0 | 2 | 0 | 833 | I | | | | | | | | | | | | | | |
9/15/23 16:05 | 9/13/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Hayes Anthony | NY | DO | CEO | P | 5 | 2.75 | 0 | 2 | 1 | 221 | I | | | | | | | | | | | | | | |
9/12/23 16:45 | 9/11/23 | DOMH | Financ | FinTrd | Security Brokers, Dealers & F | Wool Kyle Michael | NY | D | | P | 6 | 2.82 | 0 | 2 | 0 | 829 | I | | | | | | | | | | | | | | |
8/28/23 17:02 | 8/25/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 6 | 2.90 | 0 | 2 | 0 | 827 | D | | | | | | | | | | | | | | |
8/25/23 17:03 | 8/23/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 6 | 2.86 | 0 | 2 | 1 | 219 | D | | | | | | | | | | | | | | |
8/22/23 16:05 | 8/18/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P.m | 7 | 2.97 | 0 | 2 | 0 | 825 | D | | | | | | | | | | | | | | |
8/18/23 16:05 | 8/16/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 6 | 2.94 | 0 | 2 | 1 | 217 | D | | | | | | | | | | | | | | |
8/16/23 16:05 | 8/14/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 6 | 3.00 | 0 | 2 | 0 | 822 | D | | | | | | | | | | | | | | |
7/10/23 14:05 | 5/18/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Devall Christopher Franklin | NY | O | COO | P | 4 | 2.94 | 0 | 2 | 8 | 21 | D | | | | | | | | | | | | | | |
6/15/23 16:05 | 6/14/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | SC | DO | CEO | P | 4 | 2.87 | 0 | 1 | 1 | 215 | D | | | | | | | | | | | | | | |
6/14/23 16:05 | 6/13/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 1 | 2.89 | 0 | 1 | 0 | 213 | D | | | | | | | | | | | | | | |
6/12/23 16:00 | 6/9/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 4 | 2.76 | 0 | 2 | 1 | 291 | D | | | | | | | | | | | | | | |
6/9/23 21:06 | 6/8/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 1 | 2.59 | 0 | 0 | 0 | 289 | D | | | | | | | | | | | | | | |
5/31/23 08:00 | 5/30/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 5 | 2.59 | 0 | 2 | 1 | 289 | D | | | | | | | | | | | | | | |
5/26/23 17:51 | 5/18/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 0 | 2.54 | 0 | 0 | 0 | 287 | D | | | | | | | | | | | | | | |
5/25/23 08:00 | 5/24/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 6 | 2.75 | 0 | 2 | 1 | 213 | D | | | | | | | | | | | | | | |
5/22/23 08:30 | 5/18/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 6 | 2.94 | 0 | 2 | 1 | 287 | D | | | | | | | | | | | | | | |
5/18/23 08:30 | 5/17/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 6 | 2.77 | 0 | 2 | 1 | 211 | D | | | | | | | | | | | | | | |
5/18/23 08:30 | 5/17/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 6 | 2.77 | 0 | 2 | 1 | 285 | D | | | | | | | | | | | | | | |
5/17/23 08:46 | 5/16/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 5 | 2.71 | 0 | 2 | 1 | 283 | D | | | | | | | | | | | | | | |
5/17/23 08:30 | 5/16/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 6 | 2.77 | 0 | 2 | 1 | 209 | D | | | | | | | | | | | | | | |
4/5/23 19:51 | 4/5/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Devall Christopher Franklin | NY | O | COO | P | 20 | 3.51 | 0 | 6 | 41 | 20 | D | | | | | | | | | | | | | | |
4/4/23 18:58 | 4/4/23 | DOMH | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 103 | 3.44 | 0 | 30 | 17 | 207 | D | | | | | | | | | | | | | | |
12/22/22 17:15 | 12/20/22 | DOMH | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 22 | 3.59 | 0 | 6 | 2 | 281 | D | | | | | | | | | | | | | | |
12/21/22 16:15 | 12/19/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.59 | 0 | 5 | 2 | 275 | D | | | | | | | | | | | | | | |
12/20/22 17:26 | 12/16/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 19 | 3.71 | 0 | 5 | 2 | 270 | D | | | | | | | | | | | | | | |
12/19/22 09:00 | 12/15/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.69 | 0 | 5 | 2 | 288 | D | | | | | | | | | | | | | | |
12/16/22 09:00 | 12/14/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 17 | 3.69 | 0 | 5 | 3 | 177 | D | | | | | | | | | | | | | | |
12/16/22 09:00 | 12/14/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 17 | 3.69 | 0 | 5 | 2 | 283 | D | | | | | | | | | | | | | | |
12/15/22 09:00 | 12/13/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 18 | 3.70 | 0 | 5 | 3 | 172 | D | | | | | | | | | | | | | | |
12/15/22 09:00 | 12/13/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.70 | 0 | 5 | 2 | 279 | D | | | | | | | | | | | | | | |
12/14/22 09:00 | 12/12/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 18 | 3.63 | 0 | 5 | 3 | 167 | D | | | | | | | | | | | | | | |
12/14/22 09:00 | 12/12/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.63 | 0 | 5 | 2 | 274 | D | | | | | | | | | | | | | | |
12/13/22 09:00 | 12/9/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 18 | 3.68 | 0 | 5 | 3 | 162 | D | | | | | | | | | | | | | | |
12/13/22 09:00 | 12/9/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.68 | 0 | 5 | 2 | 269 | D | | | | | | | | | | | | | | |
12/12/22 09:00 | 12/8/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 18 | 3.56 | 0 | 5 | 2 | 264 | D | | | | | | | | | | | | | | |
12/12/22 09:00 | 12/8/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 18 | 3.56 | 0 | 5 | 3 | 157 | D | | | | | | | | | | | | | | |
12/9/22 09:40 | 12/7/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Wool Kyle Michael | NY | D | | P | 17 | 3.48 | 0 | 5 | 2 | 259 | D | | | | | | | | | | | | | | |
12/8/22 16:23 | 12/7/22 | AIKI | Health | Drug | Pharmaceutical Preparations | Hayes Anthony | NY | DO | CEO | P | 17 | 3.48 | 0 | 5 | 3 | 152 | D | | | | | | | | | | | | | | |
9/19/22 09:00 | 9/16/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Wool Kyle Michael | NY | D | | P | 23 | 6.54 | 0 | 4 | 2 | 230 | I | | | | | | | | | | | | | | |
9/16/22 09:00 | 9/14/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Yu Soo | NY | D | | P | 9 | 6.12 | 0 | 1 | 2 | 84 | I | | | | | | | | | | | | | | |
9/16/22 09:00 | 9/14/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Wool Kyle Michael | NY | D | | P | 18 | 6.12 | 0 | 3 | 1 | 285 | I | | | | | | | | | | | | | | |
9/15/22 09:00 | 9/13/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Yu Soo | NY | D | | P | 185 | 6.32 | 0 | 29 | 55 | 82 | D | | | | | | | | | | | | | | |
9/15/22 09:00 | 9/13/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Hayes Anthony | NY | DO | CEO | P | 158 | 6.32 | 0 | 25 | 20 | 147 | D | | | | | | | | | | | | | | |
9/15/22 09:00 | 9/13/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Wool Kyle Michael | NY | D | | P | 150 | 6.32 | 0 | 24 | 20 | 140 | D | | | | | | | | | | | | | | |
9/14/22 11:22 | 9/12/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Yu Soo | NY | D | | P | 284 | 6.33 | 0 | 45 | 561 | 53 | D | | | | | | | | | | | | | | |
9/14/22 11:21 | 9/12/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Wool Kyle Michael | NY | D | | P | 230 | 6.33 | 0 | 36 | 45 | 116 | D | | | | | | | | | | | | | | |
9/14/22 11:20 | 9/12/22 | AIKI | Health | Biolab | Commercial Physical & Biologi | Hayes Anthony | NY | DO | CEO | P | 242 | 6.33 | 0 | 38 | 45 | 122 | D | | | | | | | | | | | | | | |
5/4/21 09:00 | 5/3/21 | AIKI | Health | Biolab | Commercial Physical & Biologi | Hayes Anthony | NY | DO | CEO | P | 10 | 0.9900 | 0 | 10 | 15 | 78 | D | | | | | | | | | | | | | | |
4/30/21 09:00 | 4/29/21 | AIKI | Health | Biolab | Commercial Physical & Biologi | Hayes Anthony | NY | DO | CEO | P | 10 | 0.9900 | 0 | 10 | 17 | 68 | D | | | | | | | | | | | | | | |
4/23/21 11:10 | 4/22/21 | AIKI | Health | Biolab | Commercial Physical & Biologi | Hayes Anthony | NY | DO | CEO | P | 9 | 0.9300 | 0 | 10 | 21 | 58 | D | | | | | | | | | | | | | | |
11/20/18 08:01 | 11/19/18 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | NY | DO | CEO | P | 9 | 0.8840 | 0 | 10 | 24 | 52 | D | | | | | | | | | | | | | | |
6/7/17 18:43 | 6/7/17 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | NY | DO | CEO | P.d | 1 | 0.9985 | 0 | 1 | 31 | 4 | D | | | | | | | | | | | | | | |
5/31/17 16:08 | 5/31/17 | SPEX | Financ | Patent | Patent Owners & Lessors | Vanderzanden Robert J | NY | D | | P | 1 | 1.05 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
5/30/17 16:45 | 5/30/17 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | NY | DO | CEO | P | 1 | 1.04 | 0 | 1 | 2 | 42 | D | | | | | | | | | | | | | | |
5/26/17 17:02 | 5/26/17 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | NY | DO | CEO | P | 2 | 0.9700 | 0 | 2 | 5 | 41 | D | | | | | | | | | | | | | | |
5/25/17 18:51 | 5/25/17 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | NY | DO | CEO | P | 2 | 0.9600 | 0 | 2 | 165 | 3 | D | | | | | | | | | | | | | | |
6/10/14 12:12 | 6/9/14 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | MD | DO | CEO | P | 4 | 1.69 | 1 | 3 | 9 | 30 | D | -89 | -70 | -80 | -65 | 2 | 6 | -16 | -5 | 4 | 6 | -3 | -20 | -21 | -63 |
4/11/14 15:54 | 4/11/14 | SPEX | Financ | Patent | Patent Owners & Lessors | Hayes Anthony | MD | DOT | CEO | P | 9 | 2.35 | 0 | 4 | 17 | 27 | D | -87 | -67 | -69 | -71 | -48 | -44 | -19 | 1 | -10 | -21 | -49 | -36 | -58 | -68 |
4/3/14 17:46 | 4/3/14 | SPEX | Financ | Patent | Patent Owners & Lessors | Kesner Harvey J | MD | D | | P | 28 | 2.84 | 0 | 10 | 270 | 14 | D | -83 | -60 | -64 | -65 | -45 | -39 | -32 | -5 | -3 | -12 | -43 | -36 | -59 | -71 |
4/1/14 14:06 | 4/1/14 | SPEX | Financ | Patent | Patent Owners & Lessors | Kesner Harvey J | VA | D | | P | 15 | 3.13 | 0 | 5 | 470 | 6 | M | -84 | -64 | -63 | -64 | -39 | -38 | -30 | -33 | 1 | -20 | -47 | -40 | -69 | -72 |
1/28/14 12:06 | 1/27/14 | SPEX | Health | Biolab | Testing Laboratories | Kesner Harvey J | VA | D | | P | 6 | 5.79 | 0 | 1 | New | 1 | D | -76 | -4 | -15 | -30 | -28 | -30 | -28 | -28 | 1 | -5 | -18 | -71 | -75 | -83 |
6/7/13 17:07 | 5/31/13 | SPEX | Health | Biolab | Testing Laboratories | Kesner Harvey J | VA | DO | INTERIM | S | 0 | 0.00 | 0 | -110 | -79 | 30 | I | -92 | -60 | -34 | -54 | -24 | -19 | -12 | -1 | 0 | -8 | 4 | 91 | 46 | -67 |
4/25/06 13:43 | 4/24/06 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Vanderzanden Robert J | MD | D | | P | 3 | 2.60 | 0 | 1 | New | 1 | | | | | | | | | | -3 | -8 | -21 | -55 | -45 | 0 |
4/3/06 14:30 | 3/28/06 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Vanderzanden Robert J | MD | D | | S | -3 | 2.87 | 0 | -1 | -100 | 0 | | | | | | | | | | -3 | -4 | -9 | -43 | -51 | -14 |
12/9/05 10:22 | 12/7/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | S.m | -286 | 4.66 | 0 | -61 | -2 | 2,446 | M | -34 | 37 | 177 | 184 | 182 | 214 | 246 | 251 | -26 | -12 | -20 | -46 | -54 | -50 |
12/9/05 10:22 | 12/8/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | P | 0 | 0.00 | 0 | 0 | 0 | 2,446 | M | -34 | 37 | 177 | 184 | 182 | 214 | 246 | 251 | -26 | -12 | -20 | -46 | -54 | -50 |
6/27/05 14:38 | 6/23/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Brown Douglas T | MD | D | | P | 17 | 1.65 | 0 | 10 | New | 10 | D | -77 | -66 | -45 | -43 | -31 | -6 | 7 | -3 | 12 | 3 | 19 | -4 | 114 | 6 |
4/12/05 09:08 | 4/8/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Baldwin Lionel V | CO | D | | P | 9 | 2.97 | 0 | 3 | 15 | 23 | D | -62 | -59 | -9 | -15 | -14 | -2 | -6 | -3 | 6 | 0 | -13 | -38 | -42 | -5 |
4/5/05 15:57 | 4/5/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Cox Paul Jr | MD | D | | P | 2 | 2.89 | 0 | 1 | 150 | 1 | D | -52 | -54 | -11 | -10 | -12 | -8 | 6 | 0 | -4 | -4 | -6 | -40 | -46 | -9 |
3/3/05 13:43 | 3/3/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Zanden Robert J Vander | MD | D | | P | 3 | 3.33 | 0 | 1 | New | 1 | D | -53 | -51 | -22 | 12 | -10 | -1 | -2 | -8 | 4 | -1 | -8 | -45 | -53 | -28 |
1/3/05 10:13 | 1/3/05 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | P | 10 | 3.44 | 0 | 3 | 0 | 2,507 | M | -57 | -50 | -31 | -2 | 4 | 4 | 7 | 7 | 5 | 3 | 9 | -10 | -46 | 6 |
12/30/04 15:12 | 12/30/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | P | 3 | 3.15 | 0 | 1 | 0 | 2,504 | M | -58 | -53 | -40 | -12 | -8 | -11 | 1 | -2 | 4 | 6 | 13 | -2 | -40 | 23 |
12/30/04 11:18 | 12/30/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | P | 3 | 3.11 | 0 | 1 | 0 | 2,503 | M | -58 | -53 | -40 | -12 | -8 | -11 | 1 | -2 | 4 | 6 | 13 | -2 | -40 | 23 |
12/30/04 08:31 | 12/29/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | P | 3 | 3.05 | 0 | 1 | 0 | 2,502 | M | -58 | -53 | -40 | -12 | -8 | -11 | 1 | -2 | 4 | 6 | 13 | -2 | -40 | 23 |
8/19/04 09:29 | 8/18/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Baldwin Lionel V | CO | D | | P | 1 | 3.78 | 0 | 0 | 2 | 20 | D | -16 | -47 | -44 | -24 | -19 | -11 | -13 | 4 | 3 | 9 | -6 | -13 | -13 | -52 |
8/12/04 12:56 | 8/11/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Gantt Thomas W | MD | DO | CEO,P | P.m | 39 | 3.86 | 0 | 10 | New | 10 | D | -25 | -53 | -49 | -47 | -32 | -15 | -19 | -16 | 13 | 10 | 13 | 4 | -4 | -47 |
6/17/04 13:58 | 6/17/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Creel George C | MD | D | | P | 5 | 5.01 | 0 | 1 | New | 1 | D | -21 | -41 | -25 | -19 | -26 | 4 | -10 | -4 | -5 | 2 | -14 | -27 | -37 | -68 |
5/20/04 10:18 | 5/19/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Cox Paul Jr | MD | D | | P | 2 | 4.92 | 0 | 0 | New | 0 | D | -18 | -28 | -35 | -32 | -31 | -27 | -23 | -20 | 1 | 9 | -1 | -20 | -36 | -54 |
3/30/04 15:16 | 3/29/04 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Baldwin Lionel V | CO | D | | S | -15 | 7.61 | 0 | -2 | -9 | 20 | D | -9 | 21 | -11 | 16 | 3 | 10 | 18 | 18 | -8 | -4 | -9 | -31 | -53 | -59 |
9/23/03 08:35 | 9/18/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | Exec Off | S | -129 | 8.22 | 0 | -16 | -1 | 2,656 | M | 42 | 33 | 31 | 4 | 8 | -8 | -5 | -4 | 1 | 0 | -15 | -19 | -23 | -57 |
9/4/03 13:53 | 9/4/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Clayton Robert | MD | H | Controll | M | 6 | 5.78 | 0 | 1 | | 0 | D | -1 | 88 | 39 | 14 | 15 | 22 | 6 | 1 | 1 | -2 | -10 | -21 | -24 | -58 |
9/4/03 13:53 | 9/4/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Clayton Robert | MD | H | Controll | S | -9 | 8.89 | 0 | -1 | -100 | 0 | D | -1 | 88 | 39 | 14 | 15 | 22 | 6 | 1 | 1 | -2 | -10 | -21 | -24 | -58 |
8/27/03 15:23 | 8/27/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Sanchez Carol Y | NC | D | | S | -39 | 9.25 | 0 | -4 | -4 | 103 | D | -3 | 96 | 51 | 13 | 16 | 22 | 21 | 9 | 2 | 1 | -6 | -27 | -21 | -54 |
8/27/03 14:59 | 8/26/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin M Karen | MD | DOT | VP,Corp. | S | -18 | 9.22 | 0 | -2 | 0 | 2,672 | M | -3 | 96 | 51 | 13 | 16 | 22 | 21 | 9 | 2 | 1 | -6 | -27 | -21 | -54 |
8/27/03 14:48 | 8/26/03 | SPEX | BizSv | EngSv | Engineering, Accounting, Rese | Levin Gilbert V | MD | DOT | CEO | S | -18 | 9.22 | 0 | -2 | 0 | 2,672 | M | -3 | 96 | 51 | 13 | 16 | 22 | 21 | 9 | 2 | 1 | -6 | -27 | -21 | -54 |